recurrence-free survival
Completion of Maintenance Bacillus Calmette Guerin Therapy Might Prolong Recurrence Free Survival in Patients with Non Muscle Invasive Bladder Cancer
... 5-year recurrence probability of up to 78%. Risk factors for recurrence are number of lesions, size of tumors, prior recurrence rate, stage, grade and concomitant CIS, with each additional risk ...
7
Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence- free survival in patients with prostate cancer
... of survival and follow-up, the date of the prostatectomy was used to represent the beginning of the follow-up ...biochemical recurrence-free ...overall survival and metastasis-free ...
10
P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients
... The purpose of this study was to examine the role of P2 purinergic signaling in the pathogenesis of HCC in patients and characterize the influence of extracellular nucleotides on HCC cell proliferation. Our analysis ...
18
Original Article Low nuclear zinc finger and BTB domain containing 7A expression is an independent prognostic factor for recurrence-free survival in invasive ductal carcinoma of the breast
... subtypes, namely luminal A; luminal B (HER2- negative); luminal B (HER2-positive), HER2 sub- type; basal phenotype; and five negative phe- notypes [27-29]. Breast cancer-expressed ho- rmonal receptors, including ER and ...
8
Reduced Connexin 43 expression is associated with tumor malignant behaviors and biochemical recurrence-free survival of prostate cancer
... To date, prostate cancer treatment decision is usually based on clinicopathological factors, such as T stage, PSA and Gleason score because these features were associated with prognosis of prostate cancer [30-33]. Among ...
9
Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ
... retrospectively. Recurrence-free survival (RFS) was assessed using the Kaplan–Meier method, and the equivalences of survival curves were tested by log-rank ...of recurrence was ...
10
SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy
... Results: In the GSE76938 cohort, 10,206 CpG sites were identified to be differentially methylated in tumour versus normal prostate tissues. Among the CpG sites, four sites (cg06480736, cg19774478, cg19788741 and ...
10
Postmastectomy locoregional recurrence and recurrence free survival in breast cancer patients
... Cumulative recurrence free survival (RFS) was determined using the Kaplan-Meier method, with univariate comparisons between groups through the log-rank ...
7
MiR-608, pre-miR-124-1 and pre-miR26a-1 polymorphisms modify susceptibility and recurrence-free survival in surgically resected CRC individuals
... and survival remains ...and recurrence-free survival in stage II cases in co-dominant and over-dominant models; additionally, a cumulative effect of rs531564 and rs7372209 at-risk genotypes ...
9
Radiofrequency Ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival
... resection have a comparable impact on overall (OS) and recurrence-free survival (RFS). Given the different therapeutic options that occur in patients with HCC in the initial stage, it is absolutely ...
13
Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival “early on” in neoadjuvant treatment of breast cancer
... with recurrence-free ...of recurrence-free survival, their change from baseline to the early treatment time point does not seem to ...of recurrence – free survival ...
9
Expression pattern of FGFR2, Grb2 and Plcγ1 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinoma
... Overall survival (OS) was defined as the time interval from surgery to the time of death or last contact and recurrence-free survival (RFS) was defined as the time interval from sur- gery to ...
20
RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung
... pyrosequencing. Recurrence was found in 268 (46%) of 578 NSCLCs with a median follow-up period of ...poor recurrence-free survival (RFS) in 128 never-smokers with adenocarcinoma ( P = ...
10
Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survival
... locoregional recurrence significantly more frequently than patients without overexpression of ...local recurrence-free survival rates were ...local recurrence-free ...
10
PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy
... The statistical analyses were performed using SPSS, ver- sion 22 (SPSS Inc., Chicago, IL). The relationship be- tween input DNA methylation and measured DNA methylation was assessed by linear regression. State- ments ...
12
Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer
... Human PCa cell lines (LNCaP, PC3, DU145, and 22Rv1) and a prostatic normal epithelial cell line (RWPE-1) were obtained from the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences (Shanghai, ...
10
Original Article Relationship of different surgical margins with recurrence-free survival in patients with hepatocellular carcinoma
... early period, tumor invasion and metastasis is poor, the appropriate expansion of margin could increase radical and improve prognosis; while in the later period of HCC, there might be occult in microvessels or invasion ...
6
Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer
... Indeed, at present, urologists face the dilemma of de- ciding which treatment is best adapted for hrPCa patients: ADT, radiotherapy, RP or a multimodality ap- proach. When asked, most physicians commonly say they prefer ...
7
Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients
... overall survival and recurrence-free survival for patients with adenocarcinoma or adenoacanthoma as compared to other tumor types (papil- lary, clear-cell carcinoma, and ...disease-free ...
9
Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
... tumor, survival, disease progression, cancer survival, survival time, survival rate, progression, progression-free survival, time to progres- sion, time to disease progression, ...
10